Jeffrey Arcara

Corporate Officer/Principal presso CORVUS PHARMACEUTICALS, INC.

Patrimonio netto: - $ in data 31/05/2024

55 anni

Health Technology

Consumer Services

Profilo

Jeffrey S.
Arcara is currently the Chief Business Officer at Corvus Pharmaceuticals, Inc. He previously worked as the Vice President of Business Development at Neuromed Pharmaceuticals Ltd.
He completed his undergraduate degree at the University of Wisconsin and holds an MBA from UCLA Anderson School of Management.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
CORVUS PHARMACEUTICALS, INC. -.--%	28/02/2024	0 ( -.--% )	- $	31/05/2024

Posizioni attive di Jeffrey Arcara

Società	Posizione	Inizio
CORVUS PHARMACEUTICALS, INC.	Corporate Officer/Principal	06/02/2024

Tutte le posizioni attive di Jeffrey Arcara

Precedenti posizioni note di Jeffrey Arcara

Società	Posizione	Fine
Neuromed Pharmaceuticals Ltd. Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC.	Corporate Officer/Principal	27/01/2010

Vedi nel dettaglio l'esperienza di Jeffrey Arcara

Formazione di Jeffrey Arcara

University of Wisconsin	Undergraduate Degree
UCLA Anderson School of Management	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jeffrey Arcara

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CORVUS PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Neuromed Pharmaceuticals Ltd. Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC.	Health Technology